Zenex International Inc

What Zenex International Inc does

Zenex International is a specialty pharmaceutical stockist, distributor, and retailer headquartered in Bangalore, Karnataka, India. The company distributes a comprehensive portfolio of specialty medicines across therapeutic categories including Anti-infectives, Anesthesia, Vaccines/immunoglobulin, Cardiology, Narcotic and Schedule-X drugs, Nephrology, Antidotes, Oxytocin, Parenteral nutrition, Critical Care, CNS, and Nuclear Medicines. It serves approximately 3,000 customers across Bangalore, comprising super-speciality hospitals, nursing homes, government hospitals, registered doctors, retail pharmacies, and individual patients. Notable anchor customers include Columbia Asia Hospital, M.S. Ramaiah Hospital, Narayana Hrudayalaya, and Sarga Pharma, with multi-year supply relationships spanning 5–12+ years.

The company's operational backbone is a customized in-house software system deployed on dedicated servers connected via LAN, providing real-time access to management, sales, and finance reports. Distribution is supported by a two-wheeler fleet for routine last-mile deliveries (operated by delivery personnel equipped with mobile phones for real-time coordination) and a dedicated four-wheeler for bulk orders. Cold chain capability is a core competency: walk-in refrigerators and freezers operate on a 24-hour basis with auxiliary power backup, and temperature-sensitive products are transported in thermostat containers with refrozen coolant packs to maintain product profile during transit.

Zenex operates a B2B and B2C sales-led go-to-market model with negotiated pricing through registered business accounts, requiring valid drug licenses and GST certificates for activation. Patient-facing prescription orders are captured through a dedicated patient registration portal, and a digital ordering platform (klusterlive.com) complements the field-sales motion. The company is privately held under founder/owner V.V. Mannapur, with no disclosed institutional funding, M&A activity, or public listing. Headcount is reported as 1–10 employees, though operational scope implies a larger contracted field and delivery workforce. Sources also note an Oklahoma City address and a 1976 founding date for Zenex International Inc as a U.S. entity, which conflicts with the Indian operating reality established by the website, Indian phone numbers (+91), Bangalore address, and India-specific regulatory references — this U.S. attribution appears to be a data-quality issue rather than a separate operating entity.

Name

Zenex International Inc

Legal name

Zenex International

Website

https://zenexinternational.in

Company type

Private

Founded year

1976

Operating status

Operating

Headcount range

1–10 employees

Short description

Zenex International is a Bangalore-based specialty pharmaceutical distributor serving approximately 3,000 customers—including super-speciality hospitals, nursing homes, government hospitals, doctors, and patients—with cold-chain delivery of critical care, nuclear, and other specialty medicines.

Ownership category

akta.pro rank

Product category

Specialty Pharmaceutical Distribution

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Pharmaceutical Distributors (HLAIAJAB)

Keywords

• Specialty pharmaceutical distribution
• Pharma stockist services
• Cold chain logistics
• Hospital medicine supply
• Critical care pharmaceuticals

Headquarters

HQ city

Bangalore

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D

Revenue model

1. Pharmaceutical Product Distribution: Zenex International distributes specialty pharmaceutical products including Anti-infective, Anesthesia, Vaccines/immunoglobulin, Cardiology, Narcotic, Schedule-X, Nephrology, Antidotes, Oxytocin, Parenteral nutrition, Critical Care, CNS, Nuclear Medicines and other speciality medicines to pharmacies, hospitals, doctors, retail medical stores, healthcare institutions, corporate customers, and patients.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Zenex International is a specialty pharmaceutical stockist, distributor, and retailer based in Bangalore, India, distributing a broad portfolio of specialty medicines across therapeutic categories including Anti-infective, Anesthesia, Vaccines/Immunoglobulin, Cardiology, Narcotic, Schedule-X, Nephrology, Antidotes, Oxytocin, Parenteral Nutrition, Critical Care, CNS, and Nuclear Medicines. The company serves approximately 3,000 customers including nursing homes, hospitals, government hospitals, doctors, retail medical stores, and patients across Bangalore city, supported by cold chain storage, computerized inventory management, and a direct delivery fleet.

Product overview

Zenex International is a specialty pharmaceutical stockiest/distributor/retailer based in Bangalore, India. The company operates as a B2B and B2C pharmaceutical distribution business offering a comprehensive portfolio of specialty medicines across therapeutic categories including Anti-infectives, Anti-diabetic, Anesthesia, Cardiology, Gynecology, Nephrology, Vaccines, Parenteral Nutrition, Critical Care, CNS, Narcotic Drugs, Schedule-X, Antidotes, Nuclear Medicines, and Dermatology. Their product portfolio spans hundreds of pharmaceutical products from multiple manufacturers, distributed to approximately 3000 customers including nursing homes, hospitals, government hospitals, doctors, pharmacies, and patients throughout Bangalore. The company provides cold-chain storage and distribution capabilities, computerized inventory management systems, and operates dedicated logistics for timely delivery of temperature-sensitive products.

Differentiator

Problem solved

Functional benefit

Products and services

• Specialty Pharmaceutical Distribution

Quantifiable outcome

• 3000 customers served across Bangalore city

Named customers4 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

Broad incumbents

• McKesson Corporation: Global pharmaceutical distribution and wholesale leader with specialty pharma distribution arms serving hospitals, specialty clinics, and pharmacies. Comparable as a specialty pharmaceutical distributor at vastly larger scale, providing a benchmark for the structural economics of specialty pharma distribution.
• Medline Industries: Privately held U.S. medical supply manufacturer and distributor serving hospitals, surgery centers, and physician offices with a growing specialty drug and medical-surgical distribution footprint. Comparable as a privately held broad incumbent in healthcare distribution, providing a benchmark for a scaled, founder-influenced private distribution business.
• Cencora (formerly AmerisourceBergen): One of the world's largest pharmaceutical distributors with a dedicated specialty distribution and physician services business. Comparable as a broad incumbent in the same specialty pharmaceutical distribution category, offering strategic reference points on specialty-pharma economics and compliance.
• Cardinal Health: U.S.-based pharmaceutical and medical products distributor with a specialty distribution segment serving hospitals and physician offices. Comparable as a broad incumbent in pharmaceutical distribution providing scale, cold-chain, and specialty drug handling benchmarks.

Regional players

• Sinopharm Group: State-affiliated pharmaceutical and medical device distributor in China with dominant share in the domestic hospital supply market. Comparable as a large regional pharmaceutical distributor serving institutional hospital customers with a specialty drug portfolio.
• Zuellig Pharma: Asia's largest pharmaceutical distribution and healthcare services group, headquartered in Singapore, with extensive reach across South and Southeast Asia. Comparable as a specialty pharmaceutical distributor serving Asia-Pacific hospitals and healthcare providers, providing regional benchmarking for cold-chain and specialty drug handling.

Direct peers

• Medplus Health Services: India's second-largest pharmacy retail and distribution chain, operating retail stores and wholesale pharmaceutical supply across multiple states. Directly comparable as a pharmaceutical distributor serving hospitals, doctors, and patients, with a far larger geographic footprint than Zenex.
• Tata 1mg: Online pharmacy and pharmaceutical distribution platform combining retail medicine delivery with B2B supply to hospitals and clinics across India. Comparable as a digital-first pharmaceutical distributor targeting the same broad mix of patients, doctors, and institutions, with national reach.
• Apollo Pharmacy: India's largest organized pharmacy chain and a major pharmaceutical distributor serving hospitals, clinicians, and retail customers nationwide. Comparable as a multi-channel pharmaceutical stockist and distributor, with broader specialty drug coverage and integrated supply chain.
• PharmEasy (including Netmeds/Thyrocare): Online pharmacy and diagnostics platform with nationwide medicine delivery and B2B distribution partnerships. Comparable as a B2B/B2C pharmaceutical distributor and retailer serving patients and healthcare providers, with scale advantages in digital ordering and customer acquisition.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zenex International Inc